Achei.com.br - Acetylcholinesterase inhibitor - Wikipedia

Provided by Alexa ranking, achei.com.br has ranked N/A in N/A and 2,847,512 on the world. achei.com.br reaches roughly 1,091 users per day and delivers about 32,723 users each month. The domain achei.com.br uses a Commercial suffix and it's server(s) are located in N/A with the IP number 54.157.155.100 and it is a .com.br domain.

WEBAcetylcholinesterase inhibitors ( AChEIs) also often called cholinesterase inhibitors, [1] inhibit the enzyme acetylcholinesterase from breaking down the neurotransmitter acetylcholine into choline and acetate, [2] thereby increasing both the level and duration of action of acetylcholine in the central nervous system, autonomic ganglia and ...

List of domain same IP 54.157.155.100

Search Results related to achei.com.br on Search Engine

Acetylcholinesterase inhibitor - Wikipedia
wikipedia.org

https://en.wikipedia.org/wiki/Acetylcholinesterase_inhibitor

WEBAcetylcholinesterase inhibitors ( AChEIs) also often called cholinesterase inhibitors, [1] inhibit the enzyme acetylcholinesterase from breaking down the neurotransmitter acetylcholine into choline and acetate, [2] thereby increasing both the level and duration of action of acetylcholine in the central nervous system, autonomic ganglia and ...

DA: 53 PA: 27 MOZ Rank: 66

Cholinesterase inhibitors - Drugs.com
drugs.com

https://www.drugs.com/drug-class/cholinesterase-inhibitors.html

WEBDrugs.com provides accurate and independent information on more than 24,000 prescription drugs, over-the-counter medicines and natural products. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. Data sources include Micromedex (updated 1 Apr 2024), Cerner Multum™ …

DA: 80 PA: 16 MOZ Rank: 37

Efficacy of Acetylcholinesterase Inhibitors on Cognitive Function …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8615650/

WEBNov 15, 2021 · It is estimated that 115.4 million people will be affected by AD by 2050. Acetylcholinesterase inhibitors (AChEI) are the only available and approved treatment for AD. The aim of the present study was to analyse the evidence on the efficacy of the AChEI in the treatment of cognitive symptoms of Alzheimer’s disease.

DA: 82 PA: 93 MOZ Rank: 74

Acetylcholinesterase Inhibitors for Alzheimer’s disease: Past …
esmed.org

https://esmed.org/MRA/mra/article/download/2271/193545716/

WEBSince AChEi are the primary target available for the treatment of AD, it is important to understand the past, present, and potential future of this target. Hence the primary focus of this review is to describe the overall mechanism of AChEi and ACh, previous studies of AChEi agents, and the potential AChEi agents being investigated for

DA: 61 PA: 46 MOZ Rank: 65

Acetylcholinesterase inhibitors for treating dementia symptoms - a
nih.gov

https://pubmed.ncbi.nlm.nih.gov/28678552/

WEBAbstract. The prevalence of Alzheimer's disease (AD) continues to rise, while treatment options for cognitive impairment are limited. Acetylcholinesterase inhibitors (AChEIs) aim to provide symptomatic benefit for cognitive decline, however these drugs are not without adverse events (AEs).

DA: 20 PA: 20 MOZ Rank: 43

Use of AChEI and Immunosuppressives in Managing Symptoms
neurologylive.com

https://www.neurologylive.com/view/use-of-achei-and-immunosuppressives-in-managing-symptoms

WEBJun 20, 2022 · Use of AChEI and Immunosuppressives in Managing Symptoms. James F. Howard Jr., MD and Nicholas J. Silvestri MD, FAAN, share insights regarding acetylcholinesterase inhibitors and immunosuppressive therapy as first-line treatments for patients with myasthenia gravis. EP: 1.

DA: 44 PA: 100 MOZ Rank: 24

Efficacy of acetyl-cholinesterase-inhibitor (ACHEI) treatment in
sciencedirect.com

https://www.sciencedirect.com/science/article/pii/S0167494308001532

WEBJul 1, 2009 · Long-term efficacy of acetyl-cholinesterase-inhibitor (ACHEI) treatment in mild-to-moderate Alzheimer's disease (AD) is of great relevance for clinical routine and has been investigated over a 21-month period of treatment in a “real word” population.

DA: 61 PA: 49 MOZ Rank: 5

New Acetylcholinesterase Inhibitors for Alzheimer's Disease
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3246720/

WEBDec 15, 2011 · Abstract. Acetylcholinesterase (AChE) remains a highly viable target for the symptomatic improvement in Alzheimer's disease (AD) because cholinergic deficit is a consistent and early finding in AD. The treatment approach of inhibiting peripheral AchE for myasthenia gravis had effectively proven that AchE inhibition was a reachable …

DA: 68 PA: 83 MOZ Rank: 72

Factors Associated With Deprescribing Acetylcholinesterase Inhibitors
nih.gov

https://pubmed.ncbi.nlm.nih.gov/31162642/

WEBBackground/objective: Uncertainty regarding benefits and risks associated with acetylcholinesterase inhibitors (AChEIs) in severe dementia means providers do not know if and when to deprescribe. We sought to identify which patient-, provider-, and system-level characteristics are associated with AChEI discontinuation.

DA: 17 PA: 57 MOZ Rank: 88

Acetylcholinesterase inhibitor modifications: a promising strategy …
nih.gov

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4357112/

WEBAChEI, in multiple studies, have proved helpful in restoring cognition. It is not surprising that the AChEIs donepezil (Pfizer), galantamine (Janssen), and rivastigmine (Novartis) are used in symptomatic treatment of mild to moderate Alzheimer's dementia.

DA: 4 PA: 37 MOZ Rank: 83

Alexa Rank

GLOBAL RANK

2,847,512

Alexa Reach

0.0000481507

Page length

N/A

Alexa Rank Country N/A

N/A

Daily Unique Visitors

1,091

Monthly Unique Visitors

32,723

Vistor via Country

Country lang

Country code

Total visitor

Country

Country code

Total visitor

United States

6,999

Indonesia

5,475

Taiwan

1,780

United Kingdom

1,581

Brazil

1,430

Nigeria

1,250

Egypt

1,050

Hong Kong

992

Canada

992

Australia

864

Philippines

618

India

602

Malaysia

592

Spain

491

Germany

478

Mexico

458

France

432

Italy

399

Turkey

366

Iraq

334

Thailand

327

Netherlands

314

Israel

311

Cambodia

259

Algeria

200

Ireland

180

Romania

173

Jordan

160

Poland

154

Ghana

147

Argentina

141

South Africa

128

Belgium

115

Czechia

105

Ukraine

Japan

Morocco

South Korea

Lebanon

Saudi Arabia

Austria

Hungary

Sweden

Singapore

Pakistan

Bangladesh

Denmark

Greece

Alexa Traffic Graph

Alexa daily traffic trend graph

Alexa daily pageviews (percent) graph

Alexa Statistics Graph for www.nahklick.de

Alexa daily pageviews per user graph

Alexa time on site (in minutes) graph

Alexa bounce rate (percent) graph

Alexa search visits graph

SEOquake Zone

Title			Tips
Description			Tips
Keywords			Tips
Viewport			Tips
Icon
UTF-8

Mini site formation by Alexa Rank

MOZ Rank

DNS Record

Host	Type	Class	TTL	Extra
achei.com.br	A	IN	60	Ip: 54.157.70.204
achei.com.br	A	IN	60	Ip: 54.157.155.100
achei.com.br	NS	IN	21600	Target: ns-124.awsdns-15.com
achei.com.br	NS	IN	21600	Target: ns-1362.awsdns-42.org
achei.com.br	NS	IN	21600	Target: ns-2032.awsdns-62.co.uk
achei.com.br	NS	IN	21600	Target: ns-691.awsdns-22.net
achei.com.br	SOA	IN	900	Mname: ns-124.awsdns-15.com Rname: awsdns-hostmaster.amazon.com Serial: 1 Refresh: 7200 Retry: 900 Expire: 1209600 Minimum-ttl: 86400
achei.com.br	MX	IN	300	Pri: 10 Target: aspmx.l.google.com
achei.com.br	MX	IN	300	Pri: 20 Target: alt1.aspmx.l.google.com
achei.com.br	MX	IN	300	Pri: 20 Target: alt2.aspmx.l.google.com
achei.com.br	MX	IN	300	Pri: 30 Target: aspmx2.googlemail.com
achei.com.br	MX	IN	300	Pri: 30 Target: aspmx3.googlemail.com
achei.com.br	TXT	IN	60	Txt: google-site-verification=thSf06Sy_v73r8sYPiC036Vyg1WpqYnNaEH8Q-490mw Entries_0: google-site-verification=thSf06Sy_v73r8sYPiC036Vyg1WpqYnNaEH8Q-490mw

Hosting and Whois Zone

IP	54.157.155.100
Domain infomation	% Copyright (c) Nic.br % The use of the data below is only permitted as described in % full by the Use and Privacy Policy at https://registro.br/upp , % being prohibited its distribution, commercialization or % reproduction, in particular, to use it for advertising or % any similar purpose. % 2024-04-23T03:36:00-03:00 - IP: 2604:a880:4:1d0::5bb:800f domain: achei.com.br owner: GUBY NETWORK BRASIL LTDA ownerid: 03.444.488/0001-34 responsible: Adriano Rodrigues Viegas country: BR owner-c: ARV7 tech-c: ARV nserver: ns-124.awsdns-15.com nsstat: 20240420 AA nslastaa: 20240420 nserver: ns-1362.awsdns-42.org nsstat: 20240420 AA nslastaa: 20240420 nserver: ns-2032.awsdns-62.co.uk nsstat: 20240420 AA nslastaa: 20240420 nserver: ns-691.awsdns-22.net nsstat: 20240420 AA nslastaa: 20240420 created: 19960618 #9819 changed: 20210605 expires: 20260618 status: published nic-hdl-br: ARV7 person: Adriano Rodrigues e-mail: [email protected] country: BR created: 19980208 changed: 20090121 nic-hdl-br: ARV person: Andre Rodrigues e-mail: [email protected] country: BR created: 19971223 changed: 20211024 % Security and mail abuse issues should also be addressed to % cert.br, http://www.cert.br/ , respectivelly to [email protected] % and [email protected] % % whois.registro.br accepts only direct match queries. Types % of queries are: domain (.br), registrant (tax ID), ticket, % provider, CIDR block, IP and ASN.